Literature DB >> 22384856

Core dysfunction in schizophrenia: electrophysiology trait biomarkers.

I Koychev1, W El-Deredy, T Mukherjee, C Haenschel, J F W Deakin.   

Abstract

OBJECTIVE: Core symptoms of schizophrenia, particularly in the cognitive domain are hypothesized to be due to an abnormality in neural connectivity. Biomarkers of connectivity may therefore be a promising tool in exploring the aetiology of schizophrenia. We used electrophysiological methods to demonstrate abnormal visual information processing during in patients performing a simple cognitive task.
METHOD: Electrophysiological recordings were acquired from 20 chronically ill, medicated patients diagnosed with either schizophrenia or schizo-affective disorder and 20 healthy volunteers while they conducted a working memory (WM) task.
RESULTS: The patient group had significantly lower accuracy on the WM task and a trend for slower responses. An early visual evoked response potential was reduced in patients. Analysis of the electroencephalographic oscillations showed a decreased phase-locking factor (in the theta, beta and gamma bands) and signal power (theta frequency band). The beta and gamma oscillatory abnormalities were confined to two sets of correlated fronto and occipital electrodes.
CONCLUSION: The findings of event-related potential and oscillatory abnormalities in patients with schizophrenia confirm the sensitivity of early visual information processing measurements for identification of schizophrenia phenotype. The fronto-occipital distribution of the oscillatory abnormalities replicates our findings from a schizotypal sample and implicates a possible top-down dysfunction as a vulnerability trait.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22384856     DOI: 10.1111/j.1600-0447.2012.01849.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  7 in total

1.  Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.

Authors:  S Kristian Hill; Alison Buchholz; Hayley Amsbaugh; James L Reilly; Leah H Rubin; James M Gold; Richard S E Keefe; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney
Journal:  Schizophr Res       Date:  2015-05-23       Impact factor: 4.939

2.  Brain Oscillatory Correlates of Altered Executive Functioning in Positive and Negative Symptomatic Schizophrenia Patients and Healthy Controls.

Authors:  Barbara Berger; Tamas Minarik; Birgit Griesmayr; Renate Stelzig-Schoeler; Wolfgang Aichhorn; Paul Sauseng
Journal:  Front Psychol       Date:  2016-05-10

3.  Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients.

Authors:  Bjørn H Ebdrup; Martin C Axelsen; Nikolaj Bak; Birgitte Fagerlund; Bob Oranje; Jayachandra M Raghava; Mette Ø Nielsen; Egill Rostrup; Lars K Hansen; Birte Y Glenthøj
Journal:  Psychol Med       Date:  2018-12-18       Impact factor: 7.723

4.  Sleep-Wake Rhythm and Oscillatory Pattern Analysis in a Multiple Hit Schizophrenia Rat Model (Wisket).

Authors:  Leatitia Gabriella Adlan; Mátyás Csordás-Nagy; Balázs Bodosi; György Kalmár; László G Nyúl; Attila Nagy; Gabriella Kekesi; Alexandra Büki; Gyongyi Horvath
Journal:  Front Behav Neurosci       Date:  2022-01-28       Impact factor: 3.558

5.  Brain connectivity studies in schizophrenia: unravelling the effects of antipsychotics.

Authors:  Ayna B Nejad; Bjørn H Ebdrup; Birte Y Glenthøj; Hartwig R Siebner
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363

6.  Early somatosensory processing in individuals at risk for developing psychoses.

Authors:  Florence Hagenmuller; Karsten Heekeren; Anastasia Theodoridou; Susanne Walitza; Helene Haker; Wulf Rössler; Wolfram Kawohl
Journal:  Front Behav Neurosci       Date:  2014-09-11       Impact factor: 3.558

7.  Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies.

Authors:  I Koychev; D Joyce; E Barkus; U Ettinger; A Schmechtig; C T Dourish; G R Dawson; K J Craig; J F W Deakin
Journal:  Transl Psychiatry       Date:  2016-05-17       Impact factor: 6.222

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.